scPharmaceuticals to Present at the Jefferies Healthcare Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) has announced that CEO John Tucker will present at the Jefferies Healthcare Conference on June 9, 2022, at 2:00 PM EDT in New York City. The presentation will focus on the company's mission to develop and commercialize products aimed at optimizing therapies and reducing healthcare costs. A live webcast will be available on their website under the Investor Relations section. Headquartered in Burlington, MA, scPharmaceuticals specializes in outpatient treatments for acute conditions, particularly in heart failure and infectious diseases.

BURLINGTON, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9 at 2:00pm EDT at the Marriott Marquis in New York City.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When is scPharmaceuticals scheduled to present at the Jefferies Healthcare Conference?

scPharmaceuticals is scheduled to present on June 9, 2022, at 2:00 PM EDT.

Who will represent scPharmaceuticals at the Jefferies Healthcare Conference?

John Tucker, the president and CEO of scPharmaceuticals, will represent the company.

Where can I watch the scPharmaceuticals presentation live?

The live webcast of the presentation can be accessed on the Investor Relations section of scPharmaceuticals' website.

What is scPharmaceuticals' focus in the pharmaceutical industry?

scPharmaceuticals focuses on developing products that optimize therapies and improve healthcare outcomes, especially in outpatient care for heart failure and infectious diseases.

What is the stock symbol for scPharmaceuticals?

The stock symbol for scPharmaceuticals is SCPH.